Erbumine, Perindopril,
Perindopril,
Perindopril Erbumine,
Perstarium,
Pirindopril,
S 9490,
S 9490 3,
S 9490-3,
S 94903,
S-9490,
S9490,
PERINDOPRIL ERBUMINE,
107133-36-8,
ACEON,
Perindopril tert-butylamine,
Perindopril (erbumine),
McN-A-2833-109,
Perindopril erbumine [USAN],
UNII-1964X464OJ,
S-9490-3,
CHEBI:8025,
(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylic acid tert-butylamine salt,
MFCD02313824,
1964X464OJ,
(2S,3aS,7aS)-1-((S)-N-((S)-1-Carboxybutyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1),
S-9490,
Covapril,
1H-Indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,7abeta))-, compd. with 2-methyl-2-propanamine (1:1),
2-methylpropan-2-amine (2S,3aS,7aS)-1-(((S)-1-ethoxy-1-oxopentan-2-yl)-L-alanyl)octahydro-1H-indole-2-carboxylate,
(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine,
C19H32N2O5.C4H11N,
Aceon (TN),
AC1L9AYA,
Perindopril;Coversyl;Aceon,
Perindopril-Erbumine(Aceon),
DSSTox_CID_24198,
DSSTox_GSID_44198,
SCHEMBL41679,
SPECTRUM1505212,
CHEMBL1200343,
DTXSID1044198,
HY-B0130A,
Perindopril erbumine (JAN/USP),
IYNMDWMQHSMDDE-MHXJNQAMSA-N,
HMS1922N07,
HMS2093M06,
Pharmakon1600-01505212,
Tox21_303915,
CCG-39035,
CP0070,
NSC758929,
AKOS015841351,
AKOS015961912,
CS-1904,
KS-1243,
NSC-758929,
NCGC00178276-01,
NCGC00357164-01,
AC-19078,
LS-82690,
AB0105687,
AB2000130,
AX8041142,
TL8000252,
CAS-107133-36-8,
ST24048892,
C07707,
D00624,
133P368,
S9490-3,
SR-05000001835,
SR-05000001835-1,
Perindopril erbumine, United States Pharmacopeia (USP) Reference Standard,
Perindopril tert-butylamine, European Pharmacopoeia (EP) Reference Standard,
Perindopril erbumine, Pharmaceutical Secondary Standard; Certified Reference Material,
Perindopril for peak identification, European Pharmacopoeia (EP) Reference Standard,
Perindopril for stereochemical purity, European Pharmacopoeia (EP) Reference Standard,
(2S,3(infinity)S,7(infinity)S)-1-[(S)-N-[(S)-1-Carboxybutyl]alanyl]hexahydro-2-indolinecarboxylic acid, 1-ethyl ester, compound with tert-butylamine (1:1),
(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid; 2-methylpropan-2-amine,
(2S,3aS,7aS)-1-{(2S)-2-[(1S)-1-(ethoxycarbonyl)butylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid--2-methylpropan-2-amine (1/1),
(2S,3aS,7aS)-1-{(S)-2-[(S)-1-(ethoxycarbonyl)butylamino]propanoyl}octahydroindole-2-carboxylic acid--1,1-dimethylethanamine (1/1),
1H-indole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydo-, (2S-(1R(R*(R*)),2alpha,3abeta,7abeta))_,compd. With 2-methyl-2-propanamine (1:1),
1H-Indole-2-carboxylic acid,1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-,(2S,3aS,7aS)-, compd. with 2-methyl-2-propanamine (1:1)OTHER CA INDEX NAMES:2-Propanamine, 2-methyl-,(2S,3aS,7aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)butyl]amino]-1-oxopropyl]octahydro-1H-indole-2-carboxylate,
PERINDOPRIL,
Perindopril tert-Butylamine salt,
107133-36-8 (erbumine),
CID441313,
CS-O-02102,
A8019,
C19-H32-N2-O5.C4-H11-N,
Perindopril erbumine/Perindopril tert-butylamine,
82834-16-0,
1-(2-(1-ethoxycarbonylbutylamino)propanoyl)-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid 2-methyl-2-propanamine (1:1),